Search for Clinical Trial Results
Plasmacytoma - 387 Studies Found
Status | Study |
Completed |
Study Name: Comparable Investigation of One Fraction Radiotherapy and Multifraction Radiotherapy in Patients With Multiple Myeloma. Condition: Multiple Myeloma and Malignant Plasma Cell Neoplasms Date: 2013-12-19 Interventions: Radiation: External Beam radiotherapy External Beam radiotherapy |
Active, not recruiting |
Study Name: Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2009-07-17 Interventions:
|
Completed |
Study Name: Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2009-07-11 Interventions:
|
Completed |
Study Name: Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2009-05-09 Interventions:
|
Completed |
Study Name: Study of DNA Samples From Patients With Multiple Myeloma Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2009-05-09 Interventions: Genetic: polymorphism analysis |
Recruiting |
Study Name: Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma Condition: Plasmacytoma Date: 2015-07-28 Interventions:
|
Recruiting |
Study Name: Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone Condition: Solitary Osseous Plasmacytoma Date: 2015-08-04 Interventions:
|
Terminated |
Study Name: S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma Condition:
Date: 2005-05-03 Interventions:
|
Terminated |
Study Name: CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma Condition: Extramedullary Plasmacytoma Date: 2015-01-08 Interventions:
|
Recruiting |
Study Name: Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome Condition:
Date: 2016-09-26 Interventions:
|